Switch to:
Novo Nordisk A/S (NYSE:NVO)
Cash And Cash Equivalents
$2,061 Mil (As of Sep. 2014)

Novo Nordisk A/S's quarterly cash and cash equivalents increased from Mar. 2014 ($488 Mil) to Jun. 2014 ($908 Mil) and increased from Jun. 2014 ($908 Mil) to Sep. 2014 ($2,061 Mil).

Novo Nordisk A/S's annual cash and cash equivalents declined from Dec. 2011 ($2,328 Mil) to Dec. 2012 ($2,060 Mil) and declined from Dec. 2012 ($2,060 Mil) to Dec. 2013 ($2,000 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 6105365709541,5642,1652,1562,3282,0602,000

Novo Nordisk A/S Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
BS_CashAndCashEquivalents 1,4972,3452,0601,2551,4161,7252,0004889082,061
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK